Literature DB >> 3242516

Brain morphology in Duchenne muscular dystrophy: a Golgi study.

V Jagadha1, L E Becker.   

Abstract

Intellectual impairment associated with Duchenne muscular dystrophy is well recognized, although no consistent anatomic central nervous system lesions have been reported. The autopsy findings of 13 patients, ages 13-18 years, were reviewed. Intelligence quotients, ascertained in 5 patients, ranged from 46-79. Gross and microscopic examinations of brain and spinal cord revealed no consistent pattern of abnormalities. Neuropathology included neuronal loss and gliosis in spinal gray matter and tegmental brainstem, extensive Purkinje cell loss, mononuclear perivascular cuffing with cortical and subcortical gliosis, and cerebral heterotopia. Quantitative analysis of rapid Golgi impregnations of the visual cortex revealed significantly reduced dendritic length and branching of apical and basal dendrites from pyramidal neurons in 1 patient and less striking attenuation of dendritic arborization in 2 others. The literature suggests that the intellectual deficit in Duchenne muscular dystrophy is nonprogressive and unrelated to age or severity of muscle disease, although performance intelligence quotient may deteriorate with progressive muscle weakness. Golgi analysis suggested that abnormal dendritic development and arborization may underlie intellectual impairment. Although the pathogenesis of the cellular defect is not fully known, the coexistence of central nervous system and muscle pathology raises the possibility of a common molecular mechanism.

Entities:  

Mesh:

Year:  1988        PMID: 3242516     DOI: 10.1016/0887-8994(88)90047-1

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  10 in total

1.  The relationship between deficit in digit span and genotype in nonsense mutation Duchenne muscular dystrophy.

Authors:  Mathula Thangarajh; Gary L Elfring; Panayiota Trifillis; Joseph McIntosh; Stuart W Peltz
Journal:  Neurology       Date:  2018-08-22       Impact factor: 9.910

Review 2.  Mechanisms of resistance to pathogenesis in muscular dystrophies.

Authors:  J P Infante; V A Huszagh
Journal:  Mol Cell Biochem       Date:  1999-05       Impact factor: 3.396

Review 3.  Dystrophin Dp71: the smallest but multifunctional product of the Duchenne muscular dystrophy gene.

Authors:  Ramin Tadayoni; Alvaro Rendon; L E Soria-Jasso; Bulmaro Cisneros
Journal:  Mol Neurobiol       Date:  2011-11-22       Impact factor: 5.590

Review 4.  Cognitive dysfunction in Duchenne muscular dystrophy: a possible role for neuromodulatory immune molecules.

Authors:  Mark G Rae; Dervla O'Malley
Journal:  J Neurophysiol       Date:  2016-07-06       Impact factor: 2.714

5.  Diffusion tensor imaging study in Duchenne muscular dystrophy.

Authors:  Ya Fu; Yuru Dong; Chao Zhang; Yu Sun; Shu Zhang; Xuetao Mu; Hong Wang; Weihai Xu; Shiwen Wu
Journal:  Ann Transl Med       Date:  2016-03

6.  Neural integrity is maintained by dystrophin in C. elegans.

Authors:  Shan Zhou; Lihsia Chen
Journal:  J Cell Biol       Date:  2011-01-17       Impact factor: 10.539

7.  Different dystrophin-like complexes are expressed in neurons and glia.

Authors:  D J Blake; R Hawkes; M A Benson; P W Beesley
Journal:  J Cell Biol       Date:  1999-11-01       Impact factor: 10.539

8.  Brain dystrophin-glycoprotein complex: persistent expression of beta-dystroglycan, impaired oligomerization of Dp71 and up-regulation of utrophins in animal models of muscular dystrophy.

Authors:  K Culligan; L Glover; P Dowling; K Ohlendieck
Journal:  BMC Cell Biol       Date:  2001-02-02       Impact factor: 4.241

Review 9.  The roles of the dystrophin-associated glycoprotein complex at the synapse.

Authors:  Gonneke S K Pilgram; Saranyapin Potikanond; Richard A Baines; Lee G Fradkin; Jasprina N Noordermeer
Journal:  Mol Neurobiol       Date:  2009-11-09       Impact factor: 5.590

Review 10.  Dystrophin Dp71 and the Neuropathophysiology of Duchenne Muscular Dystrophy.

Authors:  Michael Naidoo; Karen Anthony
Journal:  Mol Neurobiol       Date:  2019-12-13       Impact factor: 5.590

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.